Pharma-Bio Serv (PBSV) Cash from Financing Activities (2010 - 2026)
Pharma-Bio Serv posted quarterly Cash from Financing Activities of -$1681.0 for Q1 2026, up 81.73% on a QoQ basis from -$9202.0 in Q4 2025.
Pharma-Bio Serv (PBSV) has 17 years of Cash from Financing Activities data on file, last reported at -$1681.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities changed N/A year-over-year to -$1681.0; the trailing twelve-month figure through Jan 2026 stood at -$1.8 million (down 1.55% YoY), and the FY2025 full-year result was -$1.8 million, down 1.03% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$1681.0, up from -$9202.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at -$792.0 in Q4 2023 and bottomed at -$1.8 million in Q1 2022.
- The 5-year median for Cash from Financing Activities is -$8197.5 (2024), against an average of -$626663.6.
- The widest annual swing landed in 2022, when Cash from Financing Activities sank 62248.3%; it then jumped 66.71% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at -$2379.0 in 2022, then soared by 66.71% to -$792.0 in 2023, then plunged by 120.58% to -$1747.0 in 2024, then sank by 426.73% to -$9202.0 in 2025, then soared by 81.73% to -$1681.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$1681.0 (Q1 2026), -$9202.0 (Q4 2025), and -$5004.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | -178.05 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | -70.02 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -137.18 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -112.85 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -93.16 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 13.46 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -8.42 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -10.67 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.39 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -1,681.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -1,681.00 |
| Jan 31, 2026 | -1,681.00 |
| Oct 31, 2025 | -9,202.00 |
| Oct 31, 2025 | -9,202.00 |
| Jul 31, 2025 | -5,004.00 |
| Jul 31, 2025 | -5,004.00 |
| Apr 30, 2025 | -1.74 Mn |
| Apr 30, 2025 | -1.74 Mn |
| Jul 31, 2024 | -1,747.00 |
| Jul 31, 2024 | -1,747.00 |
| Apr 30, 2024 | -1.72 Mn |
| Apr 30, 2024 | -1.72 Mn |
| Jan 31, 2024 | -7,193.00 |
| Jan 31, 2024 | -7,193.00 |
| Oct 31, 2023 | -792.00 |
| Oct 31, 2023 | -792.00 |
| Jul 31, 2023 | -5,083.00 |
| Jul 31, 2023 | -5,083.00 |
| Apr 30, 2023 | -1.75 Mn |
| Apr 30, 2023 | -1.75 Mn |
| Oct 31, 2022 | -2,379.00 |
| Oct 31, 2022 | -2,379.00 |
| Jul 31, 2022 | -9,327.00 |
| Jul 31, 2022 | -9,327.00 |
| Apr 30, 2022 | -1.74 Mn |
| Apr 30, 2022 | -1.74 Mn |
| Jan 31, 2022 | -1.78 Mn |
| Jan 31, 2022 | -1.78 Mn |
| Oct 31, 2021 | 41,113.00 |
| Oct 31, 2021 | 41,113.00 |
| Apr 30, 2021 | -1.79 Mn |
| Apr 30, 2021 | -1.79 Mn |
| Jan 31, 2021 | -2,851.00 |
| Jan 31, 2021 | -2,851.00 |
| Oct 31, 2020 | 8,217.00 |
| Oct 31, 2020 | 8,217.00 |
| Jul 31, 2020 | -2,776.00 |
| Jul 31, 2020 | -2,776.00 |
| Apr 30, 2020 | 1.93 Mn |
| Apr 30, 2020 | 1.93 Mn |
| Jan 31, 2020 | -1.73 Mn |
| Jan 31, 2020 | -1.73 Mn |
| Oct 31, 2019 | -2,665.00 |
| Oct 31, 2019 | -2,665.00 |
| Jul 31, 2019 | -3,203.00 |
| Jul 31, 2019 | -3,203.00 |
| Apr 30, 2019 | -80,557.00 |
| Apr 30, 2019 | -80,557.00 |
| Jan 31, 2019 | -69,152.00 |
| Jan 31, 2019 | -69,152.00 |
| Oct 31, 2018 | -1.78 Mn |
| Oct 31, 2018 | -1.78 Mn |
| Jul 31, 2018 | -3,347.00 |
| Jul 31, 2018 | -3,347.00 |
| Apr 30, 2018 | -3,327.00 |
| Apr 30, 2018 | -3,327.00 |
| Jan 31, 2018 | -16,945.00 |
| Jan 31, 2018 | -16,945.00 |
| Oct 31, 2017 | -8,768.00 |
| Oct 31, 2017 | -8,768.00 |
| Jul 31, 2017 | -42,502.00 |
| Jul 31, 2017 | -42,502.00 |
| Apr 30, 2017 | -12,035.00 |
| Apr 30, 2017 | -12,035.00 |
| Jan 31, 2017 | -7,800.00 |
| Jan 31, 2017 | -7,800.00 |
| Oct 31, 2016 | -7,525.00 |
| Oct 31, 2016 | -7,525.00 |
| Jul 31, 2016 | -12,703.00 |
| Jul 31, 2016 | -12,703.00 |
| Apr 30, 2016 | -13,926.00 |
| Apr 30, 2016 | -13,926.00 |
| Jan 31, 2016 | -34,547.00 |
| Jan 31, 2016 | -34,547.00 |
| Oct 31, 2015 | -47,186.00 |
| Oct 31, 2015 | -47,186.00 |
| Jul 31, 2015 | -13,597.00 |
| Jul 31, 2015 | -13,597.00 |
| Apr 30, 2015 | -36,751.00 |
| Apr 30, 2015 | -36,751.00 |
| Jan 31, 2015 | -93,190.00 |
| Jan 31, 2015 | -93,190.00 |
| Jul 31, 2014 | -12,639.00 |
| Jul 31, 2014 | -12,639.00 |
| Apr 30, 2014 | -10,294.00 |
| Apr 30, 2014 | -10,294.00 |
| Jan 31, 2014 | -10,359.00 |
| Jan 31, 2014 | -10,359.00 |
| Oct 31, 2013 | -10,156.00 |
| Oct 31, 2013 | -10,156.00 |
| Jul 31, 2013 | -9,958.00 |
| Jul 31, 2013 | -9,958.00 |
| Apr 30, 2013 | -9,759.00 |
| Apr 30, 2013 | -9,759.00 |
| Jan 31, 2013 | 100,296.00 |
| Jan 31, 2013 | 100,296.00 |
| Oct 31, 2012 | -9,719.00 |
| Oct 31, 2012 | -9,719.00 |
| Jul 31, 2012 | -7,869.00 |
| Jul 31, 2012 | -7,869.00 |
| Apr 30, 2012 | -7,701.00 |
| Apr 30, 2012 | -7,701.00 |
| Jan 31, 2012 | -7,537.00 |
| Jan 31, 2012 | -7,537.00 |
| Oct 31, 2011 | -7,371.00 |
| Oct 31, 2011 | -7,371.00 |
| Jul 31, 2011 | -7,976.00 |
| Jul 31, 2011 | -7,976.00 |
| Apr 30, 2011 | -5,391.00 |
| Apr 30, 2011 | -5,391.00 |
| Jan 31, 2011 | -4,424.00 |
| Jan 31, 2011 | -4,424.00 |
| Oct 31, 2010 | -4,336.00 |
| Oct 31, 2010 | -4,336.00 |
| Jul 31, 2010 | -11,751.00 |
| Jul 31, 2010 | -11,751.00 |